Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2016

01.02.2016 | Retinal Disorders

The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection

verfasst von: Philip Storey, Michael Dollin, Nadim Rayess, John Pitcher, Sahitya Reddy, James Vander, Jason Hsu, Sunir Garg, for the Post-Injection Endophthalmitis Study Team

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to evaluate the effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor (VEGF) medications.

Methods

In this retrospective case–control study, billing records and an infection log were used to identify all cases of endophthalmitis following intravitreal injection of ranibizumab, bevacizumab, or aflibercept between January 1, 2009 and September 30, 2013 at a single retina practice. A 28-month period when topical antibiotic drops were prescribed for use four times a day for 4 days following intravitreal injection was compared to a 21-month period when topical antibiotics were not prescribed. Patients treated during an 8-month transition period were excluded as prescription practices were changed.

Results

During the study period, a total of 172,096 anti-VEGF injections were performed. During the period when antibiotics were prescribed, 28 cases of suspected infectious endophthalmitis occurred from a total of 57,654 injections, ten of which were culture-positive. During the period when antibiotics were not used, 24 cases of suspected endophthalmitis occurred from a total of 89,825 injections, six of which were culture-positive. During the antibiotic period, four of the ten (40 %) culture-positive cases grew bacteria resistant to the prescribed prophylactic antibiotics. In contrast, none of the six culture-positive cases grew bacteria resistant to those antibiotics during the period when antibiotics were not used (odds ratio = 9.0; 95 % confidence interval = 0.40–203.3; p = 0.17).

Conclusions

The use of prophylactic topical antibiotics following intravitreal injection may lead to higher rates of antibiotic-resistant bacteria in culture-positive endophthalmitis cases.
Literatur
1.
Zurück zum Zitat Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, Post-Injection Endophthalmitis Study Team (2011) Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 118:2028–2034. doi:10.1016/j.ophtha.2011.02.034 PubMedCrossRef Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, Post-Injection Endophthalmitis Study Team (2011) Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 118:2028–2034. doi:10.​1016/​j.​ophtha.​2011.​02.​034 PubMedCrossRef
2.
Zurück zum Zitat McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 31:654–661. doi:10.1097/IAE.0b013e31820a67e4 PubMed McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 31:654–661. doi:10.​1097/​IAE.​0b013e31820a67e4​ PubMed
4.
Zurück zum Zitat Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, Group AS (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444. doi:10.1056/NEJMoa062655 PubMedCrossRef Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, Group AS (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444. doi:10.​1056/​NEJMoa062655 PubMedCrossRef
5.
6.
Zurück zum Zitat Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431. doi:10.1056/NEJMoa054481 PubMedCrossRef Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431. doi:10.​1056/​NEJMoa054481 PubMedCrossRef
7.
Zurück zum Zitat Storey P, Dollin M, Pitcher J, Reddy S, Vojtko J, Vander J, Hsu J, Garg SJ, Post-Injection Endophthalmitis Study Team (2014) The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology 121:283–289. doi:10.1016/j.ophtha.2013.08.037 PubMedCrossRef Storey P, Dollin M, Pitcher J, Reddy S, Vojtko J, Vander J, Hsu J, Garg SJ, Post-Injection Endophthalmitis Study Team (2014) The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology 121:283–289. doi:10.​1016/​j.​ophtha.​2013.​08.​037 PubMedCrossRef
9.
10.
Zurück zum Zitat Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ (2010) Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 117:2372–2378. doi:10.1016/j.ophtha.2010.03.034 PubMedCrossRef Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ (2010) Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 117:2372–2378. doi:10.​1016/​j.​ophtha.​2010.​03.​034 PubMedCrossRef
12.
Zurück zum Zitat Pagano M, Gauvreau K (2000) Principles of biostatistics. Duxbury Press, Pacific Grove Pagano M, Gauvreau K (2000) Principles of biostatistics. Duxbury Press, Pacific Grove
13.
Zurück zum Zitat Deeks JJ, Higgins JP (2010) Statistical algorithms in Review Manager 5. Statistical Methods Group of The Cochrane Collaboration: 1–11 Deeks JJ, Higgins JP (2010) Statistical algorithms in Review Manager 5. Statistical Methods Group of The Cochrane Collaboration: 1–11
14.
Zurück zum Zitat Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA (2005) Penetration pharmacokinetics of topically administered 0.5 % moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol 123:39–44. doi:10.1001/archopht.123.1.39 PubMedCrossRef Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA (2005) Penetration pharmacokinetics of topically administered 0.5 % moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol 123:39–44. doi:10.​1001/​archopht.​123.​1.​39 PubMedCrossRef
17.
Zurück zum Zitat Mamber SW, Kolek B, Brookshire KW, Bonner DP, Fung-Tomc J (1993) Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays. Antimicrob Agents Chemother 37:213–217PubMedPubMedCentralCrossRef Mamber SW, Kolek B, Brookshire KW, Bonner DP, Fung-Tomc J (1993) Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays. Antimicrob Agents Chemother 37:213–217PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Ysern P, Clerch B, Castano M, Gibert I, Barbe J, Llagostera M (1990) Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones. Mutagenesis 5:63–66PubMedCrossRef Ysern P, Clerch B, Castano M, Gibert I, Barbe J, Llagostera M (1990) Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones. Mutagenesis 5:63–66PubMedCrossRef
19.
Zurück zum Zitat Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, Group AS (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 116(57–65), e55. doi:10.1016/j.ophtha.2008.10.018 Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, Group AS (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 116(57–65), e55. doi:10.​1016/​j.​ophtha.​2008.​10.​018
21.
Zurück zum Zitat Ta CN, Chang RT, Singh K, Egbert PR, Shriver EM, Blumenkranz MS, Mino de Kaspar H (2003) Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology 110:1946–1951PubMedCrossRef Ta CN, Chang RT, Singh K, Egbert PR, Shriver EM, Blumenkranz MS, Mino de Kaspar H (2003) Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology 110:1946–1951PubMedCrossRef
22.
Zurück zum Zitat Hooper DC (2002) Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2:530–538PubMedCrossRef Hooper DC (2002) Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2:530–538PubMedCrossRef
23.
Zurück zum Zitat Mino De Kaspar H, Hoepfner AS, Engelbert M, Thiel M, Ta CN, Mette M, Schulze-Schwering M, Grasbon T, Sesma-Vea B, Casas JM, Iturralde-Goni R, Klauss V, Kampik A (2001) Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology 108:470–478PubMedCrossRef Mino De Kaspar H, Hoepfner AS, Engelbert M, Thiel M, Ta CN, Mette M, Schulze-Schwering M, Grasbon T, Sesma-Vea B, Casas JM, Iturralde-Goni R, Klauss V, Kampik A (2001) Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology 108:470–478PubMedCrossRef
Metadaten
Titel
The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection
verfasst von
Philip Storey
Michael Dollin
Nadim Rayess
John Pitcher
Sahitya Reddy
James Vander
Jason Hsu
Sunir Garg
for the Post-Injection Endophthalmitis Study Team
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2016
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-015-3035-x

Weitere Artikel der Ausgabe 2/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.